These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18754041)
21. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545 [TBL] [Abstract][Full Text] [Related]
22. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth. Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270 [TBL] [Abstract][Full Text] [Related]
23. Virus combinations and chemotherapy for the treatment of human cancers. Kumar S; Gao L; Yeagy B; Reid T Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102 [TBL] [Abstract][Full Text] [Related]
24. Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors. Nokisalmi P; Pesonen S; Escutenaire S; Särkioja M; Raki M; Cerullo V; Laasonen L; Alemany R; Rojas J; Cascallo M; Guse K; Rajecki M; Kangasniemi L; Haavisto E; Karioja-Kallio A; Hannuksela P; Oksanen M; Kanerva A; Joensuu T; Ahtiainen L; Hemminki A Clin Cancer Res; 2010 Jun; 16(11):3035-43. PubMed ID: 20501623 [TBL] [Abstract][Full Text] [Related]
25. Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer. Lefter LP; Dima S; Sunamura M; Furukawa T; Sato Y; Abe M; Chivu M; Popescu I; Horii A Cancer Gene Ther; 2009 Feb; 16(2):137-48. PubMed ID: 18772901 [TBL] [Abstract][Full Text] [Related]
26. Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells. Woo Y; Kelly KJ; Stanford MM; Galanis C; Chun YS; Fong Y; McFadden G Ann Surg Oncol; 2008 Aug; 15(8):2329-35. PubMed ID: 18454298 [TBL] [Abstract][Full Text] [Related]
27. Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides. Espenlaub S; Wortmann A; Engler T; Corjon S; Kochanek S; Kreppel F J Gene Med; 2008 Dec; 10(12):1303-14. PubMed ID: 18837065 [TBL] [Abstract][Full Text] [Related]
28. Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer. Ganesh S; Gonzalez-Edick M; Gibbons D; Ge Y; VanRoey M; Robinson M; Jooss K Cancer Gene Ther; 2009 May; 16(5):383-92. PubMed ID: 19011598 [TBL] [Abstract][Full Text] [Related]
29. Oncolytic adenoviruses for cancer gene therapy. Liu TC; Thorne SH; Kirn DH Methods Mol Biol; 2008; 433():243-58. PubMed ID: 18679628 [TBL] [Abstract][Full Text] [Related]
30. Gene therapy developments for pancreatic cancer. Bhattacharyya M; Lemoine NR Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328 [TBL] [Abstract][Full Text] [Related]
31. Coacervate microspheres as carriers of recombinant adenoviruses. Kalyanasundaram S; Feinstein S; Nicholson JP; Leong KW; Garver RI Cancer Gene Ther; 1999; 6(2):107-12. PubMed ID: 10195878 [TBL] [Abstract][Full Text] [Related]
32. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Sinkovics JG; Horvath JC Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757 [TBL] [Abstract][Full Text] [Related]
33. Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer. Kangasniemi L; Parviainen S; Pisto T; Koskinen M; Jokinen M; Kiviluoto T; Cerullo V; Jalonen H; Koski A; Kangasniemi A; Kanerva A; Pesonen S; Hemminki A Int J Cancer; 2012 Jul; 131(1):253-63. PubMed ID: 21834073 [TBL] [Abstract][Full Text] [Related]
34. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843 [TBL] [Abstract][Full Text] [Related]
36. A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by down-regulating Neu expression and preserving Rb function. Fang L; Huang Y; Hu X; Sun L; He X; Hu H; Pu Y; Cao X; Luo H; Pan S; Gu J; Su C Chem Biol Interact; 2009 Sep; 181(1):1-7. PubMed ID: 19523934 [TBL] [Abstract][Full Text] [Related]
37. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Dorer DE; Nettelbeck DM Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376 [TBL] [Abstract][Full Text] [Related]
38. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma. Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144 [TBL] [Abstract][Full Text] [Related]
39. Gene therapy in the management of oral cancer: review of the literature. Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474 [TBL] [Abstract][Full Text] [Related]